Global Information
회사소개 | 문의 | 비교리스트

세계의 분자진단 시장(용도, 기술, 최종 용도, 지역별) : COVID-19의 잠재적 영향에 관한 인사이트와 예측(2020-2024년)

Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

리서치사 Koncept Analytics
발행일 2020년 06월 상품 코드 941645
페이지 정보 영문 121 Pages
가격
US $ 1,800 ₩ 2,011,000 PDF (Single User License)
US $ 2,400 ₩ 2,682,000 PDF (Corporate User License)


세계의 분자진단 시장(용도, 기술, 최종 용도, 지역별) : COVID-19의 잠재적 영향에 관한 인사이트와 예측(2020-2024년) Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
발행일 : 2020년 06월 페이지 정보 : 영문 121 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 분자진단 시장은 2020-2024년의 예측기간 중 6.16%의 CAGR로 성장할 전망이며, 2024년에는 179억 6,000만 달러에 달할 것으로 예측됩니다. 시장의 주요 성장 촉진요인으로 감염증 출현 증가, 세계의 고령화 인구 증가, 암 발생률 증가 등을 들 수 있습니다.

세계의 분자진단(Molecular Diagnostics) 시장에 대해 조사했으며, 시장 성장 촉진요인, 동향과 과제, COVID-19 검사의 분자진단, 용도·종류·기술·최종 용도·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 개요

  • 진단
  • 분자진단
  • 분자진단의 목적

제2장 COVID-19 검사의 분자진단

  • COVID-19 진단
  • COVID-19의 분자진단
  • 분자진단 검사 벤더
  • 개발중인 COVID-19 검사
  • COVID-19 분자진단 검사 키트의 생산능력

제3장 세계의 분자진단 시장

  • 매출별 : 세계 시장
  • 매출별 : 세계 시장 예측
  • 용도별
    • 종류별
    • CT/NG 검사
    • HPV 검사
    • 종양 검사
    • 혈액 스크리닝 검사
    • 유전자 검사
  • 기술별
    • PCR 검사
  • 최종 용도별
    • 병원 및 의원
    • 진단 연구소
  • 지역별

제4장 지역 시장 분석

  • 북미
  • 서유럽
  • 아시아태평양

제5장 시장 역학

  • 성장 촉진요인
    • 감염증 급증
    • 세계의 고령화 인구 증가
    • 암증례 발생률 증가
  • 주요 동향·진전
    • 진보하는 Sample-to-Answer 분자진단 시장
    • Point of Care 진단(POCT)의 성장
    • 급성장하는 의료기기 산업
    • 혁신과 기술 개발
    • 액체생검 솔루션의 등장
    • 항생물질 내성의 타게팅
    • 진단 검사의 분산화
    • 게노믹스와 프로테오믹스의 진보
  • 시장 과제
    • 높은 초기 비용
    • 훈련을 받은 전문가의 부족
    • 적절한 인프라의 긴급한 필요성
    • 새로운 분자진단 검사 승인의 지연

제6장 경쟁 상황

  • 세계의 IVD 시장
    • 기업별 : 세계의 IVD 키트 시장 점유율
  • 세계의 분자진단 시장
    • 기업별 : 시장 점유율
    • 기업별 : 세계의 감염증 검사 시장 점유율
    • 기업별 : 세계의 혈액 스크리닝 검사 시장 점유율
    • 매출과 시가총액 비교

제7장 기업 개요

  • Roche Holding AG
  • Abbott Laboratories
  • Danaher Corporation
  • Hologic Inc.
  • Biomerieux SA
  • Thermo Fisher Scientific Inc.
KSM 20.06.25

List of Figures

  • IVD Market - Segments by Technology
  • Molecular Diagnostcs - Traditional Process
  • Molecular Diagnostics Breakdown
  • Main Purposes of Molecular Diagnostics
  • COVID-19 Spread
  • COVID-19 Diagnostics Testing
  • Working of Molecular Diagnostics Testing
  • Global Molecular Diagnostics Market by Value (2015-2019)
  • Global Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by Application (2019)
  • Global Infectious Disease Testing Market by Value (2015-2019)
  • Global Infectious Disease Testing Market Forecast by Value (2020-2024)
  • Global Infectious Disease Testing Market Value by Type (2019)
  • Global CT/NG Market by Value & Volume (2015-2019)
  • Global CT/NG Market Forecast by Value & Volume (2020-2024)
  • Global HPV Market by Value & Volume (2015-2019)
  • Global HPV Market Forecast by Value & Volume (2020-2024)
  • Global Oncology Testing Market by Value (2015-2019)
  • Global Oncology Testing Market Forecast by Value (2020-2024)
  • Global Blood Screening Testing Market by Value (2015-2019)
  • Global Blood Screening Testing Market Forecast by Value (2020-2024)
  • Global Genetic Testing Market by Value (2015-2019)
  • Global Genetic Testing Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by Technology (2019)
  • Global PCR Testing Market by Value (2015-2019)
  • Global PCR Testing Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by End Use (2019)
  • Global Hospitals & Clinics Testing Market by Value (2015-2019)
  • Global Hospitals & Clinics Testing Market Forecast by Value (2020-2024)
  • Global Diagnostics Laboratories Testing Market by Value (2015-2019)
  • Global Diagnostics Laboratories Testing Market Forecast by Value (2020-2024)
  • Global Molecular Diagnostics Market by Region (2019)
  • North America Molecular Diagnostics Market by Value (2015-2019)
  • North America Molecular Diagnostics Market Forecast by Value (2020-2024)
  • North America Molecular Diagnostics Market by Application (2019)
  • The U.S. Molecular Diagnostics Market by Value (2015-2019)
  • The U.S. Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Western Europe Molecular Diagnostics Market by Value (2015-2019)
  • Western Europe Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Western Europe Molecular Diagnostics Market by Application (2019)
  • Asia Pacific Molecular Diagnostics Market by Value (2015-2019)
  • Asia Pacific Molecular Diagnostics Market Forecast by Value (2020-2024)
  • Asia Pacific Molecular Diagnostics Market by Application (2019)
  • Worldwide Ageing Population 60 Years or Older (2015-2019)
  • Global Cancer Prevalence (2019-2024)
  • Global Sample-to-Answer Molecular Diagnostics Market Value (2015-2019)
  • Global POCT Device Sales (2015-2019)
  • Global Medical Equipment/Devices Sales (2019-2024)
  • Global IVD Kit Market Share by Company (2019)
  • Global Molecular Diagnostics Market Share by Company (2019)
  • Global Infectious Disease Testing Market Share by Company (2019)
  • Global Blood Screening Testing Market Share by Company (2019)
  • Roche Holding AG Sales by Segments (2019)
  • Roche Holding AG Sales by Geography (2019)
  • Roche Holding AG Sales and Net Income (2015-2019)
  • Abbott Laboratories Net Sales by Segment (2019)
  • Abbott Laboratories Net Sales by Region (2019)
  • Abbott Laboratories Net Sales and Net Earnings (2015-2019)
  • Danaher Corporation Sales by Segment (2019)
  • Danaher Corporation Sales by Geography Regions (2019)
  • Danaher Corporation Sales and Net Earnings (2015-2019)
  • Hologic Inc. Revenue by Segments (2019)
  • Hologic Inc. Revenue by Region (2019)
  • Hologic Inc. Revenue and Net Income (Loss) (2015-2019)
  • Biomerieux SA Sales by Segments (2019)
  • Biomerieux SA Sales by Region (2019)
  • Biomerieux SA Revenue and Net Income (2015-2019)
  • Thermo Fisher Scientific Inc. Revenue by Segments (2019)
  • Thermo Fisher Scientific Inc. Sales by Region (2019)
  • Thermo Fisher Scientific Inc. Health, Inc. Revenue and Net Income (2015-2019)

List of Tables

  • Selected Molecular Diagnostics Test Vendors (2020)
  • COVID-19 Test Launched/In Development (2020)
  • COVID-19 Moldx Test Kit Production Capacity (2020)
  • Growing Cases and Prevalence of STDs in the US (2011-2018)
  • Key Players - Revenue & Market Cap Comparison (2019)

The global molecular diagnostics market is estimated to reach US$17.96 billion in 2024, growing at a CAGR of 6.16% for the period spanning from 2020 to 2024. The factors such as rising emergence of infectious diseases rise in global ageing population, increasing incidence of cancer cases are expected to drive the market. However, growth of the industry will be challenged by high initial cost, dearth of trained professionals, urgent need for proper infrastructure and delay in the approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics (poct), booming medical devices industry, innovation and technical developments, emergence of liquid biopsy solutions, targeting anti-biotic resistance , decentralization of diagnostic testing, advances in genomics and proteomics.

The global molecular diagnostics market is segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing.

The global molecular diagnostics market is expected to grow in future mainly due to diagnosis of infectious diseases. In terms of geographical areas, North America is the major contributors to the global molecular diagnostics market supported by rising spread of infectious diseases and presence of a well-established diagnostic infrastructure, technological advancements. Asia Pacific represents the fastest growing market for molecular diagnostics with rapidly developing infrastructure and increasing investments in research and development.

Scope of the report:

The report provides a comprehensive analysis of the global molecular diagnostics market, segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing.

The major regional markets (North America, Western Europe and Asia Pacific) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Hologic Inc. , Biomerieux SA and Thermo Fisher Scientific Inc. ) are also presented in detail.

Key Target Audience:

  • Diagnostics Product Manufacturers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1. Diagnostics
  • 1.2. Molecular Diagnostics
  • 1.3. Purpose of Molecular Diagnostics

2. Molecular Diagnostics in COVID-19 Testing

  • 2.1. COVID-19 Diagnostics
  • 2.2. Molecular Diagnostics for COVID-19
  • 2.3. Molecular Diagnostics Test Vendors
  • 2.4. COVID-19 Test in Development
  • 2.5. COVID-19 Molecular Diagnostics Test Kit Production Capacity

3. Global Molecular Diagnostics Market

  • 3.1. Global Molecular Diagnostics Market by Value
  • 3.2. Global Molecular Diagnostics Market Forecast by Value
  • 3.3. Global Molecular Diagnostics Market by Application
    • 3.3.1. Global Infectious Disease Testing Market by Value
    • 3.3.2. Global Infectious Disease Testing Market Forecast by Value
    • 3.3.3. Global Infectious Disease Testing Market Value by Type
    • 3.3.4. Global CT/NG Market by Value & Volume
    • 3.3.5. Global CT/NG Market Forecast by Value & Volume
    • 3.3.6. Global HPV Testing Market by Value & Volume
    • 3.3.7. Global HPV Testing Market Forecast by Value & Volume
    • 3.3.8. Global Oncology Testing Market by Value
    • 3.3.9. Global Oncology Testing Market Forecast by Value
    • 3.3.10. Global Blood Screening Testing Market by Value
    • 3.3.11. Global Blood Screening Testing Market Forecast by Value
    • 3.3.12. Global Genetic Testing Market by Value
    • 3.3.13. Global Genetic Testing Market Forecast by Value
  • 3.4. Global Molecular Diagnostics Market by Technology
    • 3.4.1. Global PCR Testing Market by Value
    • 3.4.2. Global PCR Testing Market Forecast by Value
  • 3.5. Global Molecular Diagnostics Market by End Use
    • 3.5.1. Global Hospitals & Clinics Testing Market by Value
    • 3.5.2. Global Hospitals & Clinics Testing Market Forecast by Value
    • 3.5.3. Global Diagnostics Laboratories Testing Market by Value
    • 3.5.4. Global Diagnostics Laboratories Testing Market Forecast by Value
  • 3.6. Global Molecular Diagnostics Market by Region

4. Regional Market Analysis

  • 4.1. North America
    • 4.1.1. North America Molecular Diagnostics Market by Value
    • 4.1.2. North America Molecular Diagnostics Market Forecast by Value
    • 4.1.3. North America Molecular Diagnostics Market by Application
    • 4.1.4. The U.S. Molecular Diagnostics Market by Value
    • 4.1.5. The U.S. Molecular Diagnostics Market Forecast by Value
  • 4.2. Western Europe
    • 4.2.1. Western Europe Molecular Diagnostics Market by Value
    • 4.2.2. Western Europe Molecular Diagnostics Market Forecast by Value
    • 4.2.3. Western Europe Molecular Diagnostics Market by Application
  • 4.3. Asia Pacific
    • 4.3.1. Asia Pacific Molecular Diagnostics Market by Value
    • 4.3.2. Asia Pacific Molecular Diagnostics Market Forecast by Value
    • 4.3.3. Asia Pacific Molecular Diagnostics Market by Application

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Rising Emergence of Infectious Diseases
    • 5.1.2. Rise in Global Ageing Population
    • 5.1.3. Increasing Incidence of Cancer Cases
  • 5.2. Key Trends and Developments
    • 5.2.1. Progressing Sample-to-Answer Molecular Diagnostics Market
    • 5.2.2. Growth in Point of Care Diagnostics (POCT)
    • 5.2.3. Booming Medical Devices Industry
    • 5.2.4. Innovation and Technical Developments
    • 5.2.5. Emergence of Liquid Biopsy Solutions
    • 5.2.6. Targeting Anti-Biotic Resistance
    • 5.2.7. Decentralization of Diagnostic Testing
    • 5.2.8. Advances in Genomics and Proteomics
  • 5.3. Challenges
    • 5.3.1. High Initial Cost
    • 5.3.2. Dearth of Trained Professionals
    • 5.3.3. Urgent Need for Proper Infrastructure
    • 5.3.4. Delay in the Approval of New Molecular Diagnostic Tests

6. Competitive Landscape

  • 6.1. Global IVD Market
    • 6.1.1. Global IVD Kit Market Share by Company
  • 6.2. Global Molecular Diagnostics Market
    • 6.2.1. Global Molecular Diagnostics Market Share by Company
    • 6.2.2. Global Infectious Disease Testing Market Share by Company
    • 6.2.3. Global Blood Screening Testing Market Share by Company
    • 6.2.4. Revenue and Market Cap Comparison

7. Company Profiles

  • 7.1. Roche Holding AG
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Abbott Laboratories
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Danaher Corporation
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies
  • 7.4. Hologic Inc.
    • 7.4.1. Business Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Business Strategies
  • 7.5. Biomerieux SA
    • 7.5.1. Business Overview
    • 7.5.2. Financial Overview
    • 7.5.3. Business Strategies
  • 7.6. Thermo Fisher Scientific Inc.
    • 7.6.1. Business Overview
    • 7.6.2. Financial Overview
    • 7.6.3. Business Strategies
Back to Top
전화 문의
F A Q